Digital pathology for reporting histopathology samples, including cancer screening samples – definitive evidence from a multisite study

Azam, Ayesha S; Tsang, Yee‐Wah; Thirlwall, Jenny; Kimani, Peter K; Sah, Shatrughan; Gopalakrishnan, Kishore; Boyd, Clinton; Loughrey, Maurice B; Kelly, Paul J; Boyle, David P; Salto‐Tellez, Manuel; Clark, David; Ellis, Ian O; Ilyas, Mohammad; Rakha, Emad; Bickers, Adam; Roberts, Ian S D; Soares, Maria F; Neil, Desley A H; Takyi, Abi; Raveendran, Sinthuri; Hero, Emily; Evans, Harriet; Osman, Rania; Fatima, Khunsha; Hughes, Rhian W; McIntosh, Stuart A; Moran, Gordon W; Ortiz‐Fernandez‐Sordo, Jacobo; Rajpoot, Nasir M; Storey, Ben; Ahmed, Imtiaz; Dunn, Janet A; Hiller, Louise; Snead, David R J

doi:10.1111/his.15129

All Outputs (2)

ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Estrogen Receptor Positive Breast Cancer (2024)
Journal Article

Introduction: ATF4, a stress-responsive transcription factor that upregulates adaptive genes, is a potential prognostic marker and modulator of glutamine metabolism in breast cancer. However, its exact role remains to be elucidated. Methods: ATF4... Read More about ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Estrogen Receptor Positive Breast Cancer.

Digital pathology for reporting histopathology samples, including cancer screening samples – definitive evidence from a multisite study (2024)
Journal Article

Aims: To conduct a definitive multicentre comparison of digital pathology (DP) with light microscopy (LM) for reporting histopathology slides including breast and bowel cancer screening samples. Methods: A total of 2024 cases (608 breast, 607 GI, 6... Read More about Digital pathology for reporting histopathology samples, including cancer screening samples – definitive evidence from a multisite study.